Navigation Links
Rigel Announces Third Quarter 2011 Financial Results
Date:11/1/2011

s that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its Phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 clinical trials for asthma.

This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's expectations as to its year-end cash position and the sufficiency of its cash, cash equivalents and available-for-sale securities; the timing design, commencement and completion of clinical trials; identification of novel programs for clinical development, and the potential indications for treatment. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "may," "intend," "believe," "plan." "expect," "potential," and similar expressions are intended to identify these forward-looking statements. These forward-looking statements are based upon Rigel's current expectations and involve risks and uncertainties. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including, without limitation, risks associated with Rigel's need for additional capital, the timing and success of preclinical studies and clinical trials and the potential problems that may arise in the research and development and approval process, as well as other risks detailed from time to time in Rigel's reports with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2011. Rigel does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or und
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigel to Present at Two Upcoming Investor Conferences
2. Rigel to Present at Wells Fargo Securities Healthcare Conference
3. Rigel to Present at Jefferies Global Healthcare Conference
4. Rigel Announces Pricing of Public Offering of Common Stock
5. Rigel Announces Proposed Public Offering of Common Stock
6. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
7. Rigel Announces First Quarter Financial Results
8. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
9. Rigel to Present at Three Upcoming Investor Conferences
10. Rigel Announces Participation at Two Investor Conferences
11. Rigel to Present at JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... REDWOOD CITY, Calif. , May 22, 2015 /PRNewswire/ ... specialty pharmaceutical company focused on the development and commercialization ... breakthrough pain, today announced that interim chief executive officer ... 2015 Healthcare Conference and chief financial officer Tim ... Science Conference. Details of the two presentations are as ...
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... , May 21, 2015  Cardica, Inc. (Nasdaq: ... employee Greg Watson , the company,s vice president of ... the company,s common stock, at a per share exercise price ... The stock option was granted pursuant to Cardica, Inc.,s Inducement ... in May 2015 under Rule 5653(c)(4) of the Nasdaq Global ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a ... products for the treatment of central nervous system disorders, ... quarter ended March 31, 2012. Key Highlights: ... continues to advance towards the goal of a projected ...
... Inc. (Nasdaq: REGN ) and Bayer ... Yakuhin, Ltd. ("Bayer Yakuhin"), and Santen Pharmaceutical Co., ... Injection in Japan.  As previously announced, Bayer Yakuhin ... the Ministry of Health, Labor and Welfare (MHLW) ...
Cached Medicine Technology:Vanda Pharmaceuticals Reports First Quarter 2012 Results 2Vanda Pharmaceuticals Reports First Quarter 2012 Results 3Vanda Pharmaceuticals Reports First Quarter 2012 Results 4Vanda Pharmaceuticals Reports First Quarter 2012 Results 5Vanda Pharmaceuticals Reports First Quarter 2012 Results 6Vanda Pharmaceuticals Reports First Quarter 2012 Results 7Vanda Pharmaceuticals Reports First Quarter 2012 Results 8Vanda Pharmaceuticals Reports First Quarter 2012 Results 9Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan 2Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan 3Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan 4Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan 5Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan 6Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan 7
(Date:5/25/2015)... 2015 A recent report for Mass ... have died as a direct result of an opiate overdose ... 33% rise in overdose deaths attributed to prescription opiate medications, ... doesn’t care about geography. This issue doesn’t care about race. ... about class.” As the state of Mass. reels from the ...
(Date:5/25/2015)... Aliso Viejo, CA (PRWEB) May 25, 2015 ... generate their very own VJ neon light backdrops with a click ... camera position, scale and much more all within Final Cut Pro ... ranging from categories such as drop zones, kaleidoscope and much more ... ProDrop Light Show drop zones and text presets, users ...
(Date:5/25/2015)... Tunstall Americas announces major investment in ... of service to its Medical Answering Service customers. ... of resources, Tunstall now provides a seamless transition between ... Service to ensure superior patient satisfaction. , ... over $10 million in expanded facilities and the latest ...
(Date:5/24/2015)... May 25, 2015 Pacific Prime has announced that ... report looking at the cost of individual international health insurance. ... 2 looks at the cost of health insurance in six top ... on, Hong Kong , Singapore ... the UAE , the UK , Article ...
(Date:5/24/2015)... Dallas, TX (PRWEB) May 24, 2015 ... the Global and Chinese Enterokinase Industry, 2009-2019 Market Research ... as it is an exhaustive study on the present ... a special insight into the growing Chinese market of ... market and the overall status of the manufacturers in ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4
... ... April 13, 2009 -- Accept an illicit injection and the result ... Coalition for Injectable Safety. The recent death of a Bronx, NY ... her thighs and buttocks is an unfortunate and repeating pattern of incidents ...
... NEW YORK, April 13 When the going gets tough, ... stands to reason that Equinox Fitness Clubs is still going ... Equinox opens its second Boston location at 225 Franklin Street. ... the heart of Boston,s financial district. "After making a ...
... Proven Principles of Movement and Supportive Atmosphere to Achieve ... announced the launch of The Momentum Walk-It Challenge, encouraging ... physical activity into their lives. Between April 12 ... will be able to join The Momentum Walk-It Challenge. ...
... , , MONDAY, April 13 (HealthDay News) -- Race and genetics may ... long suspected, a new study finds. , Though racial disparities ... less apparent when zeroing in on smaller populations or geographical areas, ... report in the May 15 issue of Cancer suggests ...
... April 13 Accuray Incorporated (Nasdaq: ARAY ), ... that it will report results for its third quarter fiscal ... 2009 after the market closes.A conference call to review the ... and will be hosted by Euan S. Thomson, Ph.D., president ...
... all eyes turn to the health reform debate in Washington, Bruce ... - will urge that "everything be on the table" at ... Mr. Bodaken will participate in a keynote panel kicking off the ... with an address by Dora Hughes, counselor to the Secretary of ...
Cached Medicine News:Health News:Consumer Alert: Illegal Silicone Injections Result in Death 2Health News:Consumer Alert: Illegal Silicone Injections Result in Death 3Health News:Consumer Alert: Illegal Silicone Injections Result in Death 4Health News:Equinox Fitness Clubs Continues National Expansion with the Opening of its Second Boston Location 2Health News:Equinox Fitness Clubs Continues National Expansion with the Opening of its Second Boston Location 3Health News:Weight Watchers(R) Kicks Off Spring by Urging People to Get Moving With 'The Momentum(TM) Walk-It Challenge' 2Health News:Weight Watchers(R) Kicks Off Spring by Urging People to Get Moving With 'The Momentum(TM) Walk-It Challenge' 3Health News:Race May Not Be Key in Cancer Disparities 2Health News:Accuray Incorporated to Report Financial Results for Third Quarter Fiscal Year 2009 2Health News:Blue Shield of California CEO to Speak at World Health Care Congress in Washington D.C. 2
Micro Dissecting Curette, 5 1/2", Round....
14 cm, very delicate, round cupped jaws, straight jaws, 3.0 mm...
Wilson pituitary forcep, flattened tip, 3 mm bite, 145 mm effective....
Bayonet Pituitary Rongeur, ceramic, 9 length 165 mm, 6.5 working length....
Medicine Products: